Support and Resistance Basics
What is MACD and how to read it?
How RSI can help?
Stock Summary
Top 10 Correlated ETFs
BABA
In the News

I don't see Alibaba delisting from the U.S., says Kraneshares' Brendan Ahern
Brendan Ahern, Kraneshares CIO, joins 'The Exchange' to discuss China stocks delisting amid audit tensions and U.S.-China relations.

This Stock Could Delist From the NYSE: What It Means for Investors
Reporting issues could push Alibaba off the New York Stock Exchange.

China regulator says Alibaba, Tencent have submitted app algorithm details
China's top internet watchdog said on Friday tech giants such as Tencent Holdings and Alibaba Group have submitted details of algorithms used in some of their products, complying with a drive by authorities to tighten oversight of platform algorithms.

With Alibaba stake cut, SoftBank's Son cools toward China tech
SoftBank Group Corp's decision to sell down its Alibaba Group Holding stake for a $34 billion gain may be aimed at shoring up cash reserves, but it also underlines how CEO Masayoshi Son has cooled on China tech.

SoftBank shares rise 3% on news of trimming Alibaba stake
Shares in SoftBank Group Corp rose 3% in morning trading in Tokyo on Friday after the Japanese conglomerate said it would book a $34.1 billion gain by trimming its stake in Alibaba Group Holding.

Softbank To Raise $34 Billion In Cash By Selling Some Of Its Alibaba Stake
SoftBank Group Corp (TYO:9984) (OTCMKTS:SFTBY) is unloading a sizable chunk of its stake in Alibaba Group Holding Ltd (NYSE:BABA) (HKG:9988), raking in over $34 billion by selling one-third of its stake in the Chinese e-commerce giant via transactions involving derivatives.

SoftBank Posts $24.34bn Loss in Q2, Buyout Rumors Resurface
Softbank, the Japanese corporation and technology investment group, seems to have stumbled on hard times recently.

Why Shares of Alibaba, JD.com, and Full Truck Alliance Are Rising Today
Inflation data is coming in better than expected and the Street had some positive sentiment on Alibaba.

Alibaba Stock: Follow Masayoshi Son, Not Charlie Munger
I explain why investors should not repeat the mistakes of Charlie Munger - it is better to follow Softbank's CEO, Masayoshi Son. Mr. Son has decided to reduce his stake in Alibaba from 23.7% to 14.6% - in my opinion, this may create headwinds for BABA in the medium term.

First Eagle Dumps Alibaba, Buys Walmart
First Eagle Investment (Trades, Portfolio) disclosed its second-quarter equity portfolio earlier this month.
Financial details
Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-03-31
Metric | History | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 98.03 | 146.06 | 194.02 | 265.43 | 315.67 | |
Net income per share | 25.1 | 34.06 | 56.88 | 55.72 | 23.03 | |
Operating cash flow per share | 49.03 | 58.52 | 68.75 | 85.77 | 52.83 | |
Free cash flow per share | 37.34 | 39.28 | 51.47 | 69.79 | 52.83 | |
Cash per share | 82.34 | 78.75 | 138.26 | 178.9 | 168.4 | |
Book value per share | 143.29 | 190.8 | 287.54 | 346.91 | 350.98 | |
Tangible book value per share | 93.01 | 104.25 | 202.81 | 263.23 | 278.78 | |
Share holders equity per share | 143.29 | 190.8 | 287.54 | 346.91 | 350.98 | |
Interest debt per share | 50.58 | 54.07 | 58.04 | 68.8 | 59.93 | |
Market cap | 2985.57B | 3135.95B | 3487.48B | 4087.94B | 1718.55B | |
Enterprise value | 2911.82B | 3080.27B | 3304.26B | 3948.12B | 1669.99B | |
P/E ratio | 46.58 | 35.68 | 23.34 | 27.15 | 27.61 | |
Price to sales ratio | 11.93 | 8.32 | 6.84 | 5.7 | 2.01 | |
POCF ratio | 23.85 | 20.77 | 19.31 | 17.64 | 12.04 | |
PFCF ratio | 31.32 | 30.95 | 25.79 | 21.68 | 12.04 | |
P/B Ratio | 8.16 | 6.37 | 4.62 | 4.36 | 1.81 | |
PTB ratio | 8.16 | 6.37 | 4.62 | 4.36 | 1.81 | |
EV to sales | 11.63 | 8.17 | 6.48 | 5.5 | 1.96 | |
Enterprise value over EBITDA | 26.99 | 21 | 15.18 | 17 | 13.76 | |
EV to operating cash flow | 23.26 | 20.4 | 18.3 | 17.03 | 11.7 | |
EV to free cash flow | 30.54 | 30.4 | 24.44 | 20.93 | 11.7 | |
Earnings yield | 0.02 | 0.03 | 0.04 | 0.04 | 0.04 | |
Free cash flow yield | 0.03 | 0.03 | 0.04 | 0.05 | 0.08 | |
Debt to equity | 0.33 | 0.23 | 0.18 | 0.17 | 0.14 | |
Debt to assets | 0.39 | 0.37 | 0.34 | 0.36 | 0.36 | |
Net debt to EBITDA | -0.68 | -0.38 | -0.84 | -0.6 | -0.4 | |
Current ratio | 1.89 | 1.3 | 1.91 | 1.7 | 1.66 | |
Interest coverage | 19.44 | 11 | 17.65 | 20.04 | 3.38 | |
Income quality | 1.95 | 1.72 | 1.21 | 1.54 | 2.29 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.06 | 0.07 | 0.06 | 0.08 | 0.04 | |
Research and developement to revenue | 0.09 | 0.1 | 0.08 | 0.08 | 0.07 | |
Intangibles to total assets | 0.28 | 0.35 | 0.26 | 0.22 | 0.19 | |
Capex to operating cash flow | -0.24 | -0.33 | -0.25 | -0.19 | 0 | |
Capex to revenue | -0.12 | -0.13 | -0.09 | -0.06 | 0 | |
Capex to depreciation | -1.35 | -1.34 | -1.07 | -0.9 | 0 | |
Stock based compensation to revenue | 0.08 | 0.1 | 0.06 | 0.07 | 0 | |
Graham number | 284.5 | 382.41 | 606.63 | 659.49 | 426.51 | |
ROIC | 0.12 | 0.08 | 0.09 | 0.07 | 0.05 | |
Return on tangible assets | 0.12 | 0.14 | 0.15 | 0.11 | 0.05 | |
Graham Net | -19.26 | -49.08 | -14.87 | -27.82 | -58.57 | |
Working capital | 121.05B | 62.6B | 221.05B | 266B | 254.75B | |
Tangible asset value | 237.45B | 268.95B | 532.82B | 711.36B | 753.38B | |
Net current asset value | -23.83B | -86.22B | 20.49B | 28.1B | 25.18B | |
Invested capital | 0.34 | 0.27 | 0.19 | 0.19 | 0.15 | |
Average receivables | 41.15B | 43.42B | 50.27B | 56.92B | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 16.2B | 18.2B | 21.36B | 27.86B | 0 | |
Days sales outstanding | 37 | 28.98 | 31.24 | 28.97 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 15.46 | 15.05 | 19.21 | 24.14 | 0 | |
Receivables turnover | 9.86 | 12.6 | 11.68 | 12.6 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 23.6 | 24.25 | 19 | 15.12 | 0 | |
ROE | 0.18 | 0.18 | 0.2 | 0.16 | 0.07 | |
Capex per share | -11.69 | -19.24 | -17.28 | -15.98 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-03-31 for Q4
Metric | History | 2021-03-31 | 2021-06-30 | 2021-09-30 | 2021-12-31 | 2022-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 69.24 | 75.66 | 74.46 | 90.2 | 76.28 | |
Net income per share | -1.98 | 16.57 | 2.04 | 7.64 | -6.02 | |
Operating cash flow per share | 8.94 | 12.36 | 13.29 | 29.88 | -2.63 | |
Free cash flow per share | -7.02 | 12.36 | 13.29 | 29.88 | -2.63 | |
Cash per share | 178.62 | 177.75 | 170.38 | 184.02 | 170.12 | |
Book value per share | 346.38 | 358.74 | 357.23 | 362.26 | 354.56 | |
Tangible book value per share | 262.83 | 275.93 | 273.87 | 289.41 | 281.62 | |
Share holders equity per share | 346.38 | 358.74 | 357.23 | 362.26 | 354.56 | |
Interest debt per share | 67.47 | 55.85 | 61.02 | 52.36 | 67 | |
Market cap | 4019.37B | 4039.2B | 2613.66B | 2092.63B | 1906.4B | |
Enterprise value | 3879.55B | 3898B | 2493.21B | 1939.16B | 1857.85B | |
P/E ratio | -187.26 | 22.41 | 119.06 | 25.46 | -29.57 | |
Price to sales ratio | 21.45 | 19.63 | 13.02 | 8.63 | 9.34 | |
POCF ratio | 166.21 | 120.2 | 72.95 | 26.04 | -270.8 | |
PFCF ratio | -211.52 | 120.2 | 72.95 | 26.04 | -270.8 | |
P/B Ratio | 4.29 | 4.14 | 2.71 | 2.15 | 2.01 | |
PTB ratio | 4.29 | 4.14 | 2.71 | 2.15 | 2.01 | |
EV to sales | 20.7 | 18.95 | 12.42 | 7.99 | 9.1 | |
Enterprise value over EBITDA | 619.93 | 66.63 | 91.65 | 56.83 | 69.61 | |
EV to operating cash flow | 160.42 | 116 | 69.58 | 24.13 | -263.9 | |
EV to free cash flow | -204.17 | 116 | 69.58 | 24.13 | -263.9 | |
Earnings yield | 0 | 0.01 | 0 | 0.01 | -0.01 | |
Free cash flow yield | 0 | 0.01 | 0.01 | 0.04 | 0 | |
Debt to equity | 0.17 | 0.14 | 0.14 | 0.14 | 0.14 | |
Debt to assets | 0.36 | 0.35 | 0.36 | 0.37 | 0.36 | |
Net debt to EBITDA | -22.34 | -2.41 | -4.43 | -4.5 | -1.82 | |
Current ratio | 1.7 | 1.76 | 1.65 | 1.64 | 1.66 | |
Interest coverage | -6.61 | 24.35 | 1.18 | 5.96 | 0.44 | |
Income quality | -4.51 | 0.75 | 6.53 | 3.91 | 0.44 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.15 | 0.03 | 0.04 | 0.03 | 0.04 | |
Research and developement to revenue | 0.07 | 0.07 | 0.08 | 0.06 | 0.05 | |
Intangibles to total assets | 0.22 | 0.21 | 0.21 | 0.19 | 0.19 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 124.3 | 365.76 | 127.93 | 249.53 | 219.22 | |
ROIC | -0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
Return on tangible assets | 0 | 0.03 | 0 | 0.01 | -0.01 | |
Graham Net | -27.78 | -44.72 | -62.53 | -58.04 | -59.17 | |
Working capital | 266B | 278.94B | 250.18B | 264.63B | 254.75B | |
Tangible asset value | 711.36B | 750.33B | 738.15B | 778.37B | 753.38B | |
Net current asset value | 28.1B | 42.18B | 10.3B | 24.12B | 25.18B | |
Invested capital | 0.19 | 0.15 | 0.16 | 0.14 | 0.15 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 27.34 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 19.99 | 0 | 0 | 0 | 0 | |
Receivables turnover | 3.29 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 4.5 | 0 | 0 | 0 | 0 | |
ROE | -0.01 | 0.05 | 0.01 | 0.02 | -0.02 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |